RxDoctor Payments Data

Matthew Detemple, DO

Family Medicine · Burley, IDNPI 1467419150

Payments from drug & device makers

$326in general payments, 2019–2025

Across 20 payments — averaging $16.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$44
  • Exact Sciences$37
  • AbbVie$33
  • Pfizer$32
  • Welch Allyn$29
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$28
  • plus $122 from 6 others

What the payments were for

  • Food & beverage$29791%
  • Other$299%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$326 in reported general payments places this provider in the 55th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$2,969
Medicare patients
28
Services billed
112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide111$142,901
FarxigaDapagliflozin Propanediol85$93,387
OzempicSemaglutide59$76,976
XifaxanRifaximin12$36,696
JardianceEmpagliflozin19$33,858
EliquisApixaban50$29,205
XareltoRivaroxaban31$25,623
Breo ElliptaFluticasone/Vilanterol34$19,261
Fiasp FlextouchInsulin Aspart (Niacinamide)22$16,381
Invega SustennaPaliperidone Palmitate12$16,139
MounjaroTirzepatide13$15,842
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$10,475
PentasaMesalamine11$9,055
LinzessLinaclotide11$8,204
Lantus SolostarInsulin Glargine,hum.Rec.Anlog58$7,731

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro, Olanzapine$24$159,765135 claims
AstraZenecaFarxiga$28$93,38785 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$28$36,69612 claims
GSKBreo Ellipta, Trelegy Ellipta, Incruse Ellipta, Arnuity Ellipta$21$36,00974 claims
PfizerEliquis$32$29,20550 claims
AbbVieLinzess$33$8,20411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 803 family medicine providers in Idaho.

Other family medicine in Burley

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →